Polymyalgia Rheumatica

Also known as: Polymalgia rheumatica / Polymyalgia Rheumatica (PMR) / Polymyalgia Rheumatic (PMR) / Polymyalgia rheumatica (disorder) / Rhizomelic pseudopolyarthritis / Pseudopolyarthritis, Rhizomelic

DrugDrug NameDrug Description
DB00860PrednisoloneA glucocorticoid used to treat adrenocortical insufficiency, inflammatory conditions, and some cancers.
DB00635PrednisoneA corticosteroid used to treat inflammation or immune-mediated reactions and to treat endocrine or neoplastic diseases.
DB11767SarilumabA monoclonal antibody used to treat moderate to severe rheumatoid arthritis who have responded poorly or are intolerant of other DMARDs.
DrugDrug NameTargetType
DB00860PrednisoloneCorticosteroid-binding globulincarrier
DB00860PrednisoloneCytochrome P450 3A4enzyme
DB00860PrednisoloneGlucocorticoid receptortarget
DB00860PrednisoloneSolute carrier organic anion transporter family member 1A2transporter
DB00860PrednisoloneP-glycoprotein 1transporter
DB00860PrednisoloneSerum albumincarrier
DB00635PrednisoneGlucocorticoid receptortarget
DB00635PrednisoneCytochrome P450 3A4enzyme
DB00635PrednisoneP-glycoprotein 1transporter
DB00635PrednisoneSolute carrier organic anion transporter family member 1A2transporter
DB00635PrednisoneCytochrome P450 2C19enzyme
DB00635PrednisoneSerum albumincarrier
DB00635PrednisoneCytochrome P450 3A5enzyme
DB00635PrednisoneCorticosteroid-binding globulincarrier
DB00635PrednisoneCytochrome P450 3A Subfamilyenzyme
DB00635PrednisoneCytochrome P450 2A6enzyme
DB00635PrednisoneCytochrome P450 1B1enzyme
DB00635PrednisoneCytochrome P450 2B6enzyme
DB00635PrednisoneCytochrome P450 2C8enzyme
DB00635PrednisoneCytochrome P450 2C9enzyme
DB00635PrednisoneCorticosteroid 11-beta-dehydrogenase isozyme 1enzyme
DB11767SarilumabCytochrome P450 3A4enzyme
DB11767SarilumabInterleukin-6 receptor subunit alphatarget
DB11767SarilumabHigh affinity immunoglobulin gamma Fc receptor Itarget
DB11767SarilumabLow affinity immunoglobulin gamma Fc region receptor II-atarget
DB11767SarilumabLow affinity immunoglobulin gamma Fc region receptor II-btarget
DB11767SarilumabLow affinity immunoglobulin gamma Fc region receptor III-Atarget
DB11767SarilumabLow affinity immunoglobulin gamma Fc region receptor III-Btarget
DrugDrug NamePhaseStatusCount
DB09035Nivolumab1Terminated1
DB00860Prednisolone1Not Yet Recruiting1
DB09029Secukinumab1Recruiting1
DB00041Aldesleukin2Unknown Status1
DB11817Baricitinib2Completed1
DB06168Canakinumab2Terminated1
DB00860Prednisolone2Recruiting1
DB00635Prednisone2Completed1
DB00635Prednisone2Terminated2
DB09029Secukinumab2Terminated1
DB06273Tocilizumab2Completed1
DB08895Tofacitinib2Completed1
DB00860Prednisolone2 / 3Completed1
DB00635Prednisone2 / 3Completed1
DB01281Abatacept3Active Not Recruiting1
DB00630Alendronic acid3Completed1
DB01436Alfacalcidol3Completed1
DB11105Benzalkonium3Completed1
DB00005Etanercept3Completed1
DB00065Infliximab3Unknown Status1
DB01097Leflunomide3Unknown Status1
DB00860Prednisolone3Unknown Status1
DB00635Prednisone3Not Yet Recruiting1
DB00635Prednisone3Terminated2
DB00073Rituximab3Recruiting2
DB11767Sarilumab3Terminated1
DB09029Secukinumab3Recruiting2
DB11803Sirukumab3Withdrawn1
DB06273Tocilizumab3Completed2
DB08895Tofacitinib3Not Yet Recruiting1
DB11094Vitamin D3Completed1
DB00741Hydrocortisone4Recruiting1
DB00635Prednisone4Completed1
DB00443BetamethasoneNot AvailableUnknown Status1
DB06273TocilizumabNot AvailableCompleted1